Bruna Karina Banin Hirata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bruna Karina Banin Hirata has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Glauco Akelinghton Freire Vitiello
Department of Immunology, Parasitology and General Pathology, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, Brazil
6 shared publications - Maria Angelica Ehara Watanabe
Department of Pathological Sciences, Biological Sciences Center, Londrina State University, Londrina, PR, 86057-970, Brazil.
6 shared publications - Karen Brajão de Oliveira
Laboratory of Molecular Genetics and Immunology, Department of Pathological Sciences, Londrina State University, Londrina, PR, Brazil
5 shared publications - Roberta Losi Guembarovski
Department of Biological Sciences, Biological Sciences Center, State University of Londrina, Londrina 86057-970, PR, Brazil
4 shared publications - Carlos Eduardo Coral de Oliveira
Pontifícia Universidade Católica do Paraná, Brazil
3 shared publications Clodoaldo Zago Campos
Department of Clinical Medicine, Health Sciences Center, State University of Londrina, Paraná, Brazil
3 shared publications
Latest Publications
High‐Resolution HLA Allele and Haplotype Frequencies in a Southern Brazilian Population
The HLA system has been extensively studied due to its crucial role in the immune system, as well as its application in population, anthropological and epidemiological research. This study analysed 11 loci of HLA allele and haplotype frequency (HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQA1, ‐DQB1, ‐DPA1, ‐DPB1 and ‐DRB3/4/5) using high‐resolution next‐generation sequencing technology. A total of 5287 volunteer bone marrow donors from the Northwestern region of the state of Paraná, in Southern Brazil, were rated. Most of the analysed loci were in Hardy–Weinberg equilibrium, except for HLA‐DPA1 and ‐DPB1. The most frequent alleles were HLA‐A*02:01:01 , HLA‐B*51:01:01 and HLA‐C*04:01:01 for Class I and DRB1*07:01:01 , DRB3*02:02P , DRB4*01:01P , DRB5*01:01P , DQA1*01:02:01 , DQB1*05:01:01 , DPA1*01:03:01 and DPB1*04:01:01 for Class II. The most prevalent haplotype for ABCDRB1 alleles was HLA‐A*01:01:01 ~ B*08:01:01 ~ C*07:01:01 ~ DRB1*03:01:01 , which is typical of European descents. These results reflect a predominantly European genetic contribution, with additional African and Native American influences. These data extend understanding of genetic diversity about the Brazilian HLA system and provide information to characterise this population's HLA profile.
High‐Resolution HLA Allele and Haplotype Frequencies in a Southern Brazilian Population
The HLA system has been extensively studied due to its crucial role in the immune system, as well as its application in population, anthropological and epidemiological research. This study analysed 11 loci of HLA allele and haplotype frequency (HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQA1, ‐DQB1, ‐DPA1, ‐DPB1 and ‐DRB3/4/5) using high‐resolution next‐generation sequencing technology. A total of 5287 volunteer bone marrow donors from the Northwestern region of the state of Paraná, in Southern Brazil, were rated. Most of the analysed loci were in Hardy–Weinberg equilibrium, except for HLA‐DPA1 and ‐DPB1. The most frequent alleles were HLA‐A*02:01:01 , HLA‐B*51:01:01 and HLA‐C*04:01:01 for Class I and DRB1*07:01:01 , DRB3*02:02P , DRB4*01:01P , DRB5*01:01P , DQA1*01:02:01 , DQB1*05:01:01 , DPA1*01:03:01 and DPB1*04:01:01 for Class II. The most prevalent haplotype for ABCDRB1 alleles was HLA‐A*01:01:01 ~ B*08:01:01 ~ C*07:01:01 ~ DRB1*03:01:01 , which is typical of European descents. These results reflect a predominantly European genetic contribution, with additional African and Native American influences. These data extend understanding of genetic diversity about the Brazilian HLA system and provide information to characterise this population's HLA profile.
- 21 January 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 219 (1)
PDCD1 gene single nucleotide polymorphisms and haplotypes are associated with higher risk of breast cancer development
The programmed cell death protein 1 (PD-1), expressed mainly by T lymphocytes, is an important checkpoint of the immune response and may contribute to tumorigenesis when associated with its ligands, PD-L1 or PD-L2, expressed by tumor cells. In this context, this study aimed to analyze the allelic variants rs11568821 G > A and rs41386349 C > T of the PDCD1 gene in breast cancer (BC) patients and cancer-free women and correlate them with clinical-pathological parameters. DNA extraction was performed from peripheral blood samples, and the PDCD1 genotyping was carried out by the polymerase chain reaction technique followed by enzymatic restriction. The fragments were separated by acrylamide gel electrophoresis for genotyping. In this case–control association study, it was found that carriers of the A allele of the PDCD1 rs11568821 G > A genetic polymorphism have a higher risk of developing BC (OR = 2.42; CI 95% = 1.59–3.69; P < 0.001). This polymorphism was also correlated with positivity for estrogen (τ = 0.25; P < 0.001) and progesterone receptors (τ = 0.17; P = 0.021). The haplotypic analysis also indicated that AC allele carriers have a higher risk of BC development (OR = 2.41; CI 95% = 1.58–3.69; P < 0.001), specifically luminal A subtype (OR = 3.59; CI 95% = 2.15–5.97; P < 0.001). These results indicate that the PDCD1 rs11568821 G > A polymorphism may contribute as a potential susceptibility and prognosis marker for BC, especially for ER+/PR+ subtypes, considering the importance of PD-1 inhibitor effect over antitumor response.
- 21 January 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 219 (1)
PDCD1 gene single nucleotide polymorphisms and haplotypes are associated with higher risk of breast cancer development
The programmed cell death protein 1 (PD-1), expressed mainly by T lymphocytes, is an important checkpoint of the immune response and may contribute to tumorigenesis when associated with its ligands, PD-L1 or PD-L2, expressed by tumor cells. In this context, this study aimed to analyze the allelic variants rs11568821 G > A and rs41386349 C > T of the PDCD1 gene in breast cancer (BC) patients and cancer-free women and correlate them with clinical-pathological parameters. DNA extraction was performed from peripheral blood samples, and the PDCD1 genotyping was carried out by the polymerase chain reaction technique followed by enzymatic restriction. The fragments were separated by acrylamide gel electrophoresis for genotyping. In this case–control association study, it was found that carriers of the A allele of the PDCD1 rs11568821 G > A genetic polymorphism have a higher risk of developing BC (OR = 2.42; CI 95% = 1.59–3.69; P < 0.001). This polymorphism was also correlated with positivity for estrogen (τ = 0.25; P < 0.001) and progesterone receptors (τ = 0.17; P = 0.021). The haplotypic analysis also indicated that AC allele carriers have a higher risk of BC development (OR = 2.41; CI 95% = 1.58–3.69; P < 0.001), specifically luminal A subtype (OR = 3.59; CI 95% = 2.15–5.97; P < 0.001). These results indicate that the PDCD1 rs11568821 G > A polymorphism may contribute as a potential susceptibility and prognosis marker for BC, especially for ER+/PR+ subtypes, considering the importance of PD-1 inhibitor effect over antitumor response.
- Open Access
- 15 December 2023
- Published by Universidade Estadual de Maringa in Arquivos do Mudi
- Vol. 27 (3) , 54-63
ESTUDO TRANSVERSAL: ANÁLISE DOS EFEITOS COLATERAIS DO CONTRACEPTIVO HORMONAL E CORRELAÇÃO COM O QUADRO CLÍNICO DA COVID-19
A sintomatologia da COVID-19 é inespecífica, cujos sintomas principais são febre, tosse, dispneia, mialgias e fadiga. Tem sido observada uma disparidade na apresentação do quadro clínico da COVID-19 entre homens e mulheres, e isto pode estar relacionado aos fatores hormonais. Estudos têm demonstrado que os estrogênios estimulam a resposta imunológica humoral às infecções virais, enquanto a testosterona e a progesterona promovem uma supressão imunológica das respostas imunes inatas e mediadas por células. Dentro deste contexto, o intuito deste trabalho foi realizar um estudo observacional, no qual foi realizada coleta de dados de 200 mulheres, incluindo usuárias e não usuárias de contraceptivo hormonal, através da aplicação de um questionário. Diante dos dados analisados das participantes entrevistadas 39,5% relataram não terem tido COVID-19 e 64,5% faziam uso de algum tipo de contraceptivo hormonal. O contraceptivo hormonal do tipo oral foi associado à perda da libido (p=0,004). E o tempo de uso do contraceptivo foi associado com alteração da sensibilidade emocional (p=0,011). Neste estudo, a frequência da infecção pelo SARS-CoV-2 não variou entre as participantes usuárias e não usuárias de contraceptivo hormonal (p=0,547), no entanto, o uso deste medicamento foi associado à menor frequência de febre (p=0,032) e dispneia (p=0,006), em pacientes COVID-19-positivas. Embora este trabalho apresente algumas limitações metodológicas, foi possível gerar uma hipótese sobre a relação entre o uso do contraceptivo hormonal com o prognóstico da COVID-19, que pode ser investigada através de estudos experimentais.
- 15 December 2023
- Published by Universidade Estadual de Maringa in Arquivos do Mudi
- Vol. 27 (3) , 54-63
Open AccessESTUDO TRANSVERSAL: ANÁLISE DOS EFEITOS COLATERAIS DO CONTRACEPTIVO HORMONAL E CORRELAÇÃO COM O QUADRO CLÍNICO DA COVID-19
A sintomatologia da COVID-19 é inespecífica, cujos sintomas principais são febre, tosse, dispneia, mialgias e fadiga. Tem sido observada uma disparidade na apresentação do quadro clínico da COVID-19 entre homens e mulheres, e isto pode estar relacionado aos fatores hormonais. Estudos têm demonstrado que os estrogênios estimulam a resposta imunológica humoral às infecções virais, enquanto a testosterona e a progesterona promovem uma supressão imunológica das respostas imunes inatas e mediadas por células. Dentro deste contexto, o intuito deste trabalho foi realizar um estudo observacional, no qual foi realizada coleta de dados de 200 mulheres, incluindo usuárias e não usuárias de contraceptivo hormonal, através da aplicação de um questionário. Diante dos dados analisados das participantes entrevistadas 39,5% relataram não terem tido COVID-19 e 64,5% faziam uso de algum tipo de contraceptivo hormonal. O contraceptivo hormonal do tipo oral foi associado à perda da libido (p=0,004). E o tempo de uso do contraceptivo foi associado com alteração da sensibilidade emocional (p=0,011). Neste estudo, a frequência da infecção pelo SARS-CoV-2 não variou entre as participantes usuárias e não usuárias de contraceptivo hormonal (p=0,547), no entanto, o uso deste medicamento foi associado à menor frequência de febre (p=0,032) e dispneia (p=0,006), em pacientes COVID-19-positivas. Embora este trabalho apresente algumas limitações metodológicas, foi possível gerar uma hipótese sobre a relação entre o uso do contraceptivo hormonal com o prognóstico da COVID-19, que pode ser investigada através de estudos experimentais.
- Open Access
- 31 August 2021
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 20, 1370-1378
An association between chronic life stressors prior to diagnosis of breast cancer
The clinical course of breast cancer (BC) and survival depend on a wide range of risk factors. From the psychosomatic point of view, BC is one of the most studied type of cancer but there is no evidence available for this relation. Therefore, in the present study we evaluate the impact of chronic life stressors in BC patients. A total of 100 BC patients were invited to participate in an interview, when information about social parameters and emotional changes in the period prior to diagnosis were collected. The emotional changes were evaluated by the Holmes and Rahe's Stress Scale, which analyzes the difficulty required for a person to readjust to society after significant changes in their life. Clinicopathological parameters were obtained from the medical records. For all data, the level of significance adopted was p <0.05. It was observed that 55.2 % of the patients have a medium and 13.8 % were at high risk for disease development related to stressful events in the period prior to the BC diagnosis. The highest stress levels were presented by separated, divorced, or widowed patients compared to married (p <0.01) and single (p = 0.037) patients. The high-risk (HR) group had a lower proportion of positivity for estrogen receptor when compared to the low (LR) and moderate risk (MR) groups (p= 0.001). In addition, a binary logistic regression analysis was performed, and we found that the relationship between the estrogen receptor and the HR of chronic stress was independently associated with the histological type of BC and lymph nodes involvement. The relationship of stressful life experiences and BC is not well established, so our study collaborates with the literature to demonstrate the importance of stress as a factor associated with the development of BC.
- 31 August 2021
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 20, 1370-1378
Open AccessAn association between chronic life stressors prior to diagnosis of breast cancer
The clinical course of breast cancer (BC) and survival depend on a wide range of risk factors. From the psychosomatic point of view, BC is one of the most studied type of cancer but there is no evidence available for this relation. Therefore, in the present study we evaluate the impact of chronic life stressors in BC patients. A total of 100 BC patients were invited to participate in an interview, when information about social parameters and emotional changes in the period prior to diagnosis were collected. The emotional changes were evaluated by the Holmes and Rahe's Stress Scale, which analyzes the difficulty required for a person to readjust to society after significant changes in their life. Clinicopathological parameters were obtained from the medical records. For all data, the level of significance adopted was p <0.05. It was observed that 55.2 % of the patients have a medium and 13.8 % were at high risk for disease development related to stressful events in the period prior to the BC diagnosis. The highest stress levels were presented by separated, divorced, or widowed patients compared to married (p <0.01) and single (p = 0.037) patients. The high-risk (HR) group had a lower proportion of positivity for estrogen receptor when compared to the low (LR) and moderate risk (MR) groups (p= 0.001). In addition, a binary logistic regression analysis was performed, and we found that the relationship between the estrogen receptor and the HR of chronic stress was independently associated with the histological type of BC and lymph nodes involvement. The relationship of stressful life experiences and BC is not well established, so our study collaborates with the literature to demonstrate the importance of stress as a factor associated with the development of BC.
- 13 April 2020
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 146 (6) , 1523-1532
Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort
Purpose APOBEC3A and APOBEC3B cytidine deaminases have been implicated in the pathogenesis of multiple cancers, including breast cancer (BC). A germline deletion linking APOBEC3A and APOBEC3B loci (A3A/B) has been associated with higher APOBEC-mediated mutational burden, but its association with BC risk have been controversial. Therefore, this study investigated the association between A3A/B and BC susceptibility and clinical presentation in a Brazilian cohort. Methods A3A/B deletion was evaluated through allele-specific PCR in 341 BC patients and 397 women without familial or personal history of neoplasia from Brazil and associations with susceptibility to BC subtypes were tested through age-adjusted logistic models while correlations with clinicopathological parameters were tested using Kendall’s tests. Results No association was found between A3A/B and BC susceptibility; however, in Luminal-A BCs, it was positively correlated with tumor size (Tau-c = 0.125) and Ki67 (Tau-c = 0.116) and negatively correlated with lymph node metastasis (LNM) (Tau-c = − 0.162). The negative association between A3A/B with LNM in Luminal-A BCs remained significant even after adjusting for tumor size and Ki67 in logistic models (OR = 0.22; p = 0.008). Conclusion These results show that although A3A/B may not modify BC susceptibility in Brazilian population, it may affect clinicopathological features in BC subtypes, promoting tumor cell proliferation while being negatively associated with LNM in Luminal-A BCs.
- 13 April 2020
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 146 (6) , 1523-1532
Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort
Purpose APOBEC3A and APOBEC3B cytidine deaminases have been implicated in the pathogenesis of multiple cancers, including breast cancer (BC). A germline deletion linking APOBEC3A and APOBEC3B loci (A3A/B) has been associated with higher APOBEC-mediated mutational burden, but its association with BC risk have been controversial. Therefore, this study investigated the association between A3A/B and BC susceptibility and clinical presentation in a Brazilian cohort. Methods A3A/B deletion was evaluated through allele-specific PCR in 341 BC patients and 397 women without familial or personal history of neoplasia from Brazil and associations with susceptibility to BC subtypes were tested through age-adjusted logistic models while correlations with clinicopathological parameters were tested using Kendall’s tests. Results No association was found between A3A/B and BC susceptibility; however, in Luminal-A BCs, it was positively correlated with tumor size (Tau-c = 0.125) and Ki67 (Tau-c = 0.116) and negatively correlated with lymph node metastasis (LNM) (Tau-c = − 0.162). The negative association between A3A/B with LNM in Luminal-A BCs remained significant even after adjusting for tumor size and Ki67 in logistic models (OR = 0.22; p = 0.008). Conclusion These results show that although A3A/B may not modify BC susceptibility in Brazilian population, it may affect clinicopathological features in BC subtypes, promoting tumor cell proliferation while being negatively associated with LNM in Luminal-A BCs.
- 8 February 2018
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 32 (6) , e22406
HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility
Background: The HER2 (human epidermal growth factor receptor‐2) Ile655Val (rs1136201) genetic polymorphism can alter the receptor structure and its auto‐activation, which can modify the signal transduction and, consequently, the cell cycle regulation. For this reason, this polymorphism has been extensively investigated as a candidate marker for breast cancer (BC). In this context, the aim of this study was to evaluate the possible influence of HER2 Ile655Val in BC susceptibility and prognostic factors in a Brazilian population.Methods: Polymorphism genotype was assessed through RFLP‐PCR in 107 BC patients with clinicopathological data available and in 150 women with no evidence of neoplasia and with no familial history of BC as control group. Association between this polymorphism and BC susceptibility and clinical parameters was evaluated through odds ratio (OR) and chi‐squared or Fisher's exact test, respectively.Results: A significant negative association between valine allele and BC susceptibility in dominant model was found (OR 0.5; 95% CI 0.27‐0.93, P = .036). No significant association was found in relation to BC clinicopathological features (tumor size, lymph nodes commitment, histological grade, HER2 overexpression, hormonal receptors, p53, and Ki‐67).Conclusion: Although this polymorphism did not demonstrate potential as a prognostic marker, it may be a suitable susceptibility marker for BC.
- 8 February 2018
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 32 (6) , e22406
HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility
Background: The HER2 (human epidermal growth factor receptor‐2) Ile655Val (rs1136201) genetic polymorphism can alter the receptor structure and its auto‐activation, which can modify the signal transduction and, consequently, the cell cycle regulation. For this reason, this polymorphism has been extensively investigated as a candidate marker for breast cancer (BC). In this context, the aim of this study was to evaluate the possible influence of HER2 Ile655Val in BC susceptibility and prognostic factors in a Brazilian population.Methods: Polymorphism genotype was assessed through RFLP‐PCR in 107 BC patients with clinicopathological data available and in 150 women with no evidence of neoplasia and with no familial history of BC as control group. Association between this polymorphism and BC susceptibility and clinical parameters was evaluated through odds ratio (OR) and chi‐squared or Fisher's exact test, respectively.Results: A significant negative association between valine allele and BC susceptibility in dominant model was found (OR 0.5; 95% CI 0.27‐0.93, P = .036). No significant association was found in relation to BC clinicopathological features (tumor size, lymph nodes commitment, histological grade, HER2 overexpression, hormonal receptors, p53, and Ki‐67).Conclusion: Although this polymorphism did not demonstrate potential as a prognostic marker, it may be a suitable susceptibility marker for BC.
- 19 December 2017
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 37 (3) , 144-150
The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment
Breast cancer represents a complex and heterogeneous disease that comprises distinct disease conditions, histological features, and clinical outcome. Since many years, it has been demonstrated as an association between HER2 amplification and poor prognosis, because its overexpression is associated with an aggressive phenotype of breast tumor cells. A significant proportion of cases have developed resistance to the current therapies available. Consequently, new prognostic markers are urgently needed to identify patients who are at the highest risk for developing metastases. During the past decade, new insights provided valuable knowledge regarding mechanisms underlying the dynamic interplayed between immune cells and tumor progression. It has been shown that the presence of a lymphocytic infiltrate, particularly of regulatory T cells, in cancer tissue, is associated with clinical outcome promoting rather than inhibiting cancer development and progression. It has been also verified that the clinical value of lymphocytic infiltration in breast cancers could be subtype-dependent, including the HER2-enriched subtype. In this context, this work summarizes proposed to discuss the prognostic value of regulatory T cell infiltration in microenvironment of HER2-enriched breast cancer.
- 19 December 2017
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 37 (3) , 144-150
The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment
Breast cancer represents a complex and heterogeneous disease that comprises distinct disease conditions, histological features, and clinical outcome. Since many years, it has been demonstrated as an association between HER2 amplification and poor prognosis, because its overexpression is associated with an aggressive phenotype of breast tumor cells. A significant proportion of cases have developed resistance to the current therapies available. Consequently, new prognostic markers are urgently needed to identify patients who are at the highest risk for developing metastases. During the past decade, new insights provided valuable knowledge regarding mechanisms underlying the dynamic interplayed between immune cells and tumor progression. It has been shown that the presence of a lymphocytic infiltrate, particularly of regulatory T cells, in cancer tissue, is associated with clinical outcome promoting rather than inhibiting cancer development and progression. It has been also verified that the clinical value of lymphocytic infiltration in breast cancers could be subtype-dependent, including the HER2-enriched subtype. In this context, this work summarizes proposed to discuss the prognostic value of regulatory T cell infiltration in microenvironment of HER2-enriched breast cancer.
- Open Access
- 20 October 2015
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2015, 1-8
Genetic Polymorphism and Expression of CXCR4 in Breast Cancer
CXCR4genetic polymorphisms, as well as their expression level, have been associated with cancer development and prognosis. The present study aimed to investigate the influence ofCXCR4rs2228014 polymorphism on its mRNA and protein expression in breast cancer samples. It was observed that patients presented higherCXCR4mRNA relative expression (5.7-fold) than normal mammary gland, but this expression was not correlated with patients clinicopathological features (nuclear grade, nodal status, ER status, PR status, p53 staining, Ki67 index, and HER-2 status). Moreover,CXCR4mRNA relative expression also did not differ regarding the presence or absence of T allele (). In the immunohistochemical assay, no difference was observed for CXCR4 cytoplasmic protein staining in relation to different genotypes (); however, high cytoplasmic CXCR4 staining was verified in invasive breast carcinoma (). All in all, the results from present study indicated that rs2228014 genetic variant does not alterCXCR4mRNA or protein expression. However, this receptor was more expressed in tumor compared to normal tissue, in both RNA and protein levels, suggesting its promising applicability in the general context of mammary carcinogenesis.- 20 October 2015
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2015, 1-8
Open AccessGenetic Polymorphism and Expression of CXCR4 in Breast Cancer
CXCR4genetic polymorphisms, as well as their expression level, have been associated with cancer development and prognosis. The present study aimed to investigate the influence ofCXCR4rs2228014 polymorphism on its mRNA and protein expression in breast cancer samples. It was observed that patients presented higherCXCR4mRNA relative expression (5.7-fold) than normal mammary gland, but this expression was not correlated with patients clinicopathological features (nuclear grade, nodal status, ER status, PR status, p53 staining, Ki67 index, and HER-2 status). Moreover,CXCR4mRNA relative expression also did not differ regarding the presence or absence of T allele (). In the immunohistochemical assay, no difference was observed for CXCR4 cytoplasmic protein staining in relation to different genotypes (); however, high cytoplasmic CXCR4 staining was verified in invasive breast carcinoma (). All in all, the results from present study indicated that rs2228014 genetic variant does not alterCXCR4mRNA or protein expression. However, this receptor was more expressed in tumor compared to normal tissue, in both RNA and protein levels, suggesting its promising applicability in the general context of mammary carcinogenesis.